Want to see JP:4584 full AI Analyst Report?
Kidswell Bio Corporation (4584) Stock Statistics & Valuation Metrics
Total Valuation
Kidswell Bio Corporation has a market cap or net worth of JPY 7.59B. The enterprise value is JPY 6.45B.
- Market Cap
- JPY 7.59B
- Enterprise Value
- JPY 6.45B
Share Statistics
Kidswell Bio Corporation has 50,604,187 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 50,604,187
- Owned by Insiders
- ―
- Owned by Institutions
- 0.10%
Financial Efficiency
Kidswell Bio Corporation’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -3.22%.
- Return on Equity (ROE)
- -0.25
- Return on Assets (ROA)
- -0.07
- Return on Invested Capital (ROIC)
- -3.22%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 205.94M
- Profits Per Employee
- -12.94M
- Employee Count
- 32
- Asset Turnover
- 1.08
- Inventory Turnover
- 13.32
Valuation Ratios
The current PE Ratio of Kidswell Bio Corporation is -17.76. Kidswell Bio Corporation’s PEG ratio is 0.08.
- PE Ratio
- -17.76
- PS Ratio
- 1.09
- PB Ratio
- 3.65
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.08
Income Statement
In the last 12 months, Kidswell Bio Corporation had revenue of 6.59B and earned -413.99M in profits. Earnings per share was -8.48.
- Revenue
- 6.59B
- Gross Profit
- 1.75B
- Operating Income
- -138.51M
- Pretax Income
- -402.93M
- Net Income
- -413.99M
- EBITDA
- -138.26M
- Earnings Per Share (EPS)
- -8.48
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Kidswell Bio Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -5.49%
Stock Price Statistics
- Beta
- 1.14
- 52-Week Price Change
- -41.60%
- 50-Day Moving Average
- 161.36
- 200-Day Moving Average
- 191.69
- Relative Strength Index (RSI)
- 30.49
- Average Volume (3m)
- 286.63K
Important Dates
Kidswell Bio Corporation upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Kidswell Bio Corporation as a current ratio of 2.72, with Debt / Equity ratio of 154.18%
- Current Ratio
- 2.72
- Quick Ratio
- 2.55
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- 5.39
- Interest Coverage Ratio
- -2.82
Taxes
In the past 12 months, Kidswell Bio Corporation has paid 11.07M in taxes.
- Income Tax
- 11.07M
- Effective Tax Rate
- -0.03
Enterprise Valuation
Kidswell Bio Corporation EV to EBITDA ratio is -27.81, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.98
- EV to EBITDA
- -27.81
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Kidswell Bio Corporation has JPY 3.23B in cash and marketable securities with JPY 2.48B in debt, giving a net cash position of JPY 758.53M billion.
- Cash & Marketable Securities
- JPY 3.23B
- Total Debt
- JPY 2.48B
- Net Cash
- JPY 758.53M
- Net Cash Per Share
- JPY 14.99
- Tangible Book Value Per Share
- JPY 37.01
Margins
Gross margin is 25.76%, with operating margin of -1.74%, and net profit margin of -6.08%.
- Gross Margin
- 25.76%
- Operating Margin
- -1.74%
- Pretax Margin
- -5.56%
- Net Profit Margin
- -6.08%
- EBITDA Margin
- -3.54%
- EBIT Margin
- -3.54%
Analyst Forecast
The average price target for Kidswell Bio Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.86%
- EPS Growth Forecast
- -210.09%
Scores
- Smart Score
- ―
- AI Score
- 45
